Integrating China in the International Consortium for Personalized Medicine Project: Main Goals

News

Mar 30, 2023

Integrating China in the International Consortium for Personalized Medicine (IC2PerMed) project aims to support European Union (EU)-China collaboration over the developments of personalized medicine research, innovations, and policies through the International Consortium for Personalized Medicine (ICPerMed) initiative, providing people with access to personalized, smart, and inclusive healthcare solutions in the near future.

The IC2PerMed project’s core objective is to:

  • Map policies, programs, standards, and initiatives related to personalized medicine in Europe and China to identify opportunities for research collaborations.
  • Structure the developments of an ecosystem of European and Chinese experts, collaborating to foster actionable approaches.
  • Exemplify research collaboration frameworks between China and Europe for personalized medicine by connecting biobanks.
  • Set strong bridges with key official organisms involved in the definition and implementation of personalized medicine and healthcare systems in both economic areas in international contexts through relevant initiatives and networks.

WFPHA is one of the key partners in the IC2PerMed project.